News

Richard_Gliklich_132-792940-1408599351663.jpg

Last October, Outcome Sciences announced its collaboration with the National Football League to update its Injury Surveillance System (ISS), since then, the pilot has been completed during the course of the 2011 NFL season and rolled out to all the teams for 2012.

PC14223_articlerailheader-790132-1408596648244.jpg

The somewhat-awkwardly named TransCelerate BioPharma immediately got an enthusiastic reception from industry watchers and participants, mainly due to the perception that it was well poised to attack some of the systemic causes of delays and cost overruns that plague clinical trials today.